Bengt Furberg

Bengt Furberg has a PhD and MD in clinical physiology and is an expert in clinical trials with several books and scientific articles within the field. He spent 10 years as Medical Director of British GlaxoWellcome in Sweden and was also part of the company's management team in addition to being member of the corporate group's Medical Board and Safety Board. Bengt Furberg currently works as VP of Medical Affairs at Artimplant.

Curt Furberg

Curt Furberg is a Professor in Public Health Sciences at Wake Forest University, NC, US and is an expert in clinical trials and drug safety. Previous experiences include leading the worlds largest clinical trial on high blood pressure with over 33,000 patients. He is also member of editorial boards of leading medical journals and has over 350 scientific publications. In addition, Curt Furberg is a former member of the Committee for Risk Management and Drug Safety at FDA and has spent over 12 years at National Institutes of Health.  

Roger Henriksson

Roger Henriksson is a Professor in Experimental Oncology and Chief Physician, Medical Oncology and Radiotherapy since 1994. He is also Medical Director (advisor) at Astra Zeneca, globally, part time since 2000. Roger Henriksson has about 250 publications in peer review journals, including publications in all phases of drug development. Current scientific positions include Head/Deputy Head of the Dept of Radiation Sciences, Chairman of the National (Nordic 2001) Group for Treatment of CNS Tumours, Member of the Scientific Advisory Board for the Swedish Cancer Society, Board Member of the National Group for Treatment of Lungcancer. 

Dan Magnusson

Dan Magnusson has a M.Sc. in Pharmacy. He has broad experience from pharma industry production and from acting as Qualified Person. Previous experiences include working as International Marketing Manager for Astra/Hässle for the international launch of Losec.